---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-050412"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T23:07:37.886205+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# agilon health receives NYSE delisting notice; plans reverse stock split

## Summary
- NYSE notified agilon on Nov 5, 2025 that avg closing price was below $1.00 over 30 trading days ended Nov 4, 2025.
- Stock continues trading on NYSE during six-month cure period; no immediate impact on listing or business operations.
- To regain compliance, agilon intends to seek shareholder approval for a reverse stock split at 2026 annual meeting.
- Company must notify NYSE by Nov 19, 2025 of intent to remain listed and cure the deficiency.
- If reverse split approved and implemented, share price must promptly exceed $1.00 and stay above for at least 30 trading days.

## SEC filing metadata
- accession: 0001628280-25-050412
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000162828025050412/0001628280-25-050412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000162828025050412/agl-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-050412
- JSON: https://secwatch.observer/filing/0001628280-25-050412.json
- Plain text: https://secwatch.observer/filing/0001628280-25-050412.txt

## Source-grounded claims
- claim_id: b9b3bb169811a4d060bb32cc4506745a25e69c66
  claim: agilon health, inc. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).
  evidence_excerpt: November 5, 2025, agilon health, inc. (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) informing the Company that it is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period ended November 4, 2025 (the “Price Criteria for Capital or Common Stock”). The Company can regain compliance at any time within the six-month period following receipt of the Notice if, on the last trading day of an
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000162828025050412/0001628280-25-050412-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.